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The extracellular microenvironment in bone marrow (BM) is known to regulate the growth and differentiation of hematopoietic
stem and progenitor cells (HSPC). We have developed cell-free matrices from a BM stromal cell line (HS-5), which can be used
as substrates either in native form or as tissue engineered coatings, for the enhanced ex vivo expansion of umbilical cord blood
(UCB) derived HSPC. The physicochemical properties (surface roughness, thickness, and uniformity) of native and spin coated
acellular matrices (ACM) were studied using scanning and atomic force microscopy (SEM and AFM). Lineage-specific expansion
ofHSPC, grown on these substrates, was evaluated by immunophenotypic (flow cytometry) and functional (colony forming) assays.
Our results show that the most efficient expansion of lineage-specific HSPC occurred on spin coated ACM. Our method provides
an improved protocol for ex vivo HSPC expansion and it offers a system to study the in vivo roles of specific molecules in the
hematopoietic niche that influence HSPC expansion.
1. Introduction
Human stromal cells, residing in hematopoietic niches in
the BM, provide cellular and molecular signals that are
essential for the regulation of hematopoiesis [1]. Many tissue
engineered biological and nonbiological scaffolds have been
used for ex vivo expansion of HSPC. Bioengineered 2D and
3D scaffolds, whichmimic the in vivo functional properties of
hematopoietic niches, are gaining importance in the research
and clinical trials [2]. These scaffolds mainly comprise ACM
that are prepared by decellularizing either the whole tissue
[3], organ, or cultured stromal cells [4]. The ACM comprises
specific extracellular matrix (ECM) components, such as
fibrous and nonfibrous collagen, fibronectin or laminin,
glycosaminoglycans (GAGs), proteoglycans, growth factors,
and cytokines [5]. These components individually or col-
lectively provide biological cues that regulate proliferation,
differentiation, and survival of stem and progenitors cells of
different types in vivo [6]. Some cell types that have been
expanded on ACM-based substrates include mesenchymal
stem cells (MSCs) [7], neuronal cells [8], osteocytes [9], and
embryonic stem cell-derived hepatic cells [10].
A recent study has shown that substrates containing a
cocktail of fibronectin, heparin sulphate, tropocollagen I,
hyaluronic acid, and cofibrils of collagen I bound to heparin
or hyaluronic acid can be used for the adhesion, proliferation,
and differentiation of human HSPC [11]. A few earlier studies
have used these matrix components individually for the same
purpose [12, 13]. However, utilization of the entire ACM
as substrates or scaffolds for ex vivo lineage-specific HSPC
expansion has been limited.
We have previously shown that ACM, prepared from a
mouse BM stromal cell line (MS-5), can mimic the endosteal
and/or vascular niche-like properties of human BM and
support ex vivo expansion of UCB HSPC [4]. Our results
showed that MS-5 cell line derived ACM could support a
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significant level (up to 80-fold) of common myeloid progen-
itor (CMP) cell expansion [4]. In order to develop a more
clinically relevant nonxenogeneic model, we report here the
potential of ACM generated by human BM stromal cell line
(HS-5) on supporting HSPC expansion. HS-5 cells have a
fibroblast-like morphology and secrete significant levels of
various cytokines, such as granulocyte colony-stimulating
factor (G-CSF), granulocyte-macrophage-CSF (GM-CSF),
macrophage-CSF (M-CSF), Kit Ligand (KL), macrophage-
inhibitory protein-1 alpha, interleukin-6, interleukin-8, and
interleukin-11 (IL-6, IL-8, and IL-11) into the culture media
[14]. Intact HS-5 cells and their conditioned media have
been shown to support the proliferation of HSPC in serum-
deprived conditions [14]. For clinical use, it would be prefer-
able to be able to manufacture a standardised ACM product,
and we have therefore compared the effects of native HS-5
ACM to a sonicated and solubilised ACM preparation that
can be spin-coated onto cell culture surfaces.
2. Materials and Methods
2.1. Preparation of CD34+ Cells. UCB samples were collected
from full-term delivery with informed and signed consents
following the local ethical guidelines of the institution. Each
cord blood sample was collected, by the trained clinicians,
into the blood collection bags containing 49mL of citrate
phosphate dextrose anticoagulant (CPDA). Standard proto-
cols were followed for isolation of the target cell (CD34+)
population from UCB for multilineage ex vivo expansion
using the previously reported method [15]. Briefly, the UCB
was processed by density gradient centrifugation using Ficoll
Paque (GE Healthcare Bio-Sciences, Sweden) to obtain the
totalmononuclear cells (MNCs). CD34+ cellswere isolated by
using CD34 MicroBead Kit, in AutoMACS (Miltenyi Biotec
Inc., Germany) by the magnetic assisted cell sorting (MACS)
method. Observed cell enrichment was more than 90%. The
percentage purity of the MACS-sorted cells was determined
by a preexpansion flow-cytometry assay for CD34+CD45lo,
CD34+CD38−, and CD34+CD133+ cells surface markers that
represent different levels ofHSPCdifferentiation.The isolated
UCB CD34+ cells were further cultured on ACM substrates.
Phenotypic analysis of expanded cells was performed by flow
cytometry and functional analysis by colony forming unit
assays.
2.2. HS-5 Cell Culture
2.2.1. HS-5 Culture Maintenance. HS-5 cell line was obtained
from American Type Culture Collection (ATCC, Cat. num-
ber CRL-11882). HS-5 cells were cultured in complete growth
medium containing 𝛼-MEM, 10% FBS, 1% Pen/Strep, and 1%
GlutaMAX. Cultured cells were maintained in 5% CO
2
, 20%
O
2
, and 90% humidity in standard cell culture incubators
with regular media change. The cells were grown until they
were 80–90% confluent before splitting to the next passage.
2.2.2. HS-5 Cells for HSPC Expansion. HS-5 cells were main-
tained in complete growth medium as discussed above. After
the cells reached 80% confluency, they were shifted to a
media containing 1% FBS to limit the mitotic activity of the
cells. These mitotically inactive cells were used as cellular
control to expand UCB derived HSPC. All experiments were
performed with cells maintained within 4–6 passages. Blank
tissue culture plates (TCP) without any matrix or cells were
used as negative control throughout all the expansion and
matrix characterization experiments.
2.3. ACM Preparation
2.3.1. Native ACM. Native ACM was prepared by decel-
lularization of HS-5 cells. Cells were maintained in com-
plete growth medium for cellular control as described in
Section 2.2.2. Before decellularization, cells were further
grown for additional 4 days after confluency for better
ECM deposition. All procedures for decellularization were
done under sterile conditions as mentioned elsewhere [15]
(summarised in Figure 1). Briefly, equal numbers of HS-5
cells grown on 24-well plates (Becton Dickinson Biosciences
Labwares, USA) were washed with phosphate buffer saline
(PBS) and then incubated in MilliQ water until the shape
of cells became round. The cells were treated with 0.02M
NH
4
OH and the residual cellular matrices were retained on
the surface. ACM was dried and washed with PBS to remove
traces of NH
4
OH.The ACM obtained on 24-well plates were
used as native ACM substrates.
2.3.2. Spin Coated ACM. For spin coating, ACM sus-
pensions obtained from 60mm dishes were pooled and
briefly sonicated and total protein content was estimated.
The fine matrix suspension was immediately processed for
spin coating the 24-well tissue culture plates (TCP) for
expansion purpose. Based on the total estimated matrix
protein in each well of 24-well plate (see Supplementary
Table 1 of the Supplementary Material available online
at http://dx.doi.org/10.1155/2016/7231567), equal amounts of
ACM (∼50 𝜇g protein) were placed on each well of a 24-well
TCP or borosilicate glass coverslips (18 × 18mm) and spin
coated for 60 sec at 1000 rpm under vacuum, using aWS-400
6NPP-Lite Spin Coater (Laurell Technologies Corporation,
USA) under sterile conditions (Figure 1). The process was
repeated three times to get maximum layering. The coated
plates and coverslips were dried overnight in the laminar flow
cabinet, washed in PBS with Pen/Strep, and used for ex vivo
HSPC expansion and ACM characterization process. Each
expansion experiment was done in freshly prepared and spin
coated ACM substrate. The amount of protein coated and
the parameters of spin coating were kept standard for each
experiment.
2.4. ACM Characterization
2.4.1. Phase Contrast Microscopy. HS-5 stromal cells and
native ACM were incubated with 4% formaldehyde for
20min at room temperature (RT) followed by washing with
1x PBS. Fixed cells and matrices were observed under light
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Figure 1: Preparation of spin coated HS-5 acellular matrices. (a) Decellularization of HS-5 cells. (b) Physical characterization of the acellular
matrices. (c) Spin coating process: step 1—extraction and collection of acellular matrices, step 2—sample kept on tissue culture surfaces to be
coated, which is held in vacuum on a stub, step 3—spinning at fixed rpm, and step 4—coating and drying under sterile conditions.
microscope (Axioplan 2, Carl Zeiss, Germany). Image acqui-
sition and processing was done using AxioVision software
(Version Release 4.4, Carl Zeiss, Germany).
2.4.2. Scanning Electron Microscopy. Morphological charac-
terization of the native and spin coated ACM was performed
by SEM. Both substrates were rinsed in PBS, fixed in 2.5%
glutaraldehyde, washed and dehydrated in increasing con-
centrations of ethyl alcohol (50%, 60%, 70%, 80%, 90%, and
100%), and finally kept in acetone. The fixed and dehydrated
samples were then subjected to critical point drying (CPD)
and sputter coatingwith a thin layer of gold.The sampleswere
examined at a range of 5–10 kV in the microscope (3400N,
Hitachi, Japan).
2.4.3. Atomic Force Microscopy. Freshly prepared native and
spin coated ACM was dried in a dehumidified desiccator
for 16 h and subjected to AFM measurements. AFM analysis
was carried out in 200–300 kHz tapping modes using a
multiprobe imaging microscope Multiview 4000TM (Nanonics
Imaging Ltd., Israel) equipped with a hybrid scanner. Images
were collected at scanning frequencies of 5 kHz using glass
tip cantilevers at 512 × 512 pixels resolution. Scan regions
of 5 × 5 or 2 × 2 𝜇m2 were used for data collection and
data of multiple scan regions were gathered and averaged
(as indicated in Section 3). Root-mean-square values were
used to calculate average surface roughness. For calculation
of the coating thickness, a scratch on the native or spin coated
surface was made to expose the underlying plastic or glass
surface and differences in the data values of the scratched
and exposed surfaces were used to calculate the thickness of
the matrix. For final image reconstruction and calculation of
height variations, thickness, and surface roughness, software
provided by the manufacturers (WSxM v4.3) was used.
2.5. Cytochemical Characterization. Various cytochemical
stains were used to stain the native and spin coated ACM
for detection of major ECM components. The presence of
collagenous matrix in the native and spin coated ACM
was demonstrated by staining with Masson’s Trichrome kit
(Sigma, USA) as instructed by the manufacturer. Similarly,
fibrillar collagen was detected by staining the native and
spin coated ACM with Picro Sirius Red. Proteoglycans and
ECM-bound GAGs were detected by staining with Safranin-
O and Alcian Blue, respectively. Details of each of these
staining protocols have been described in the supplementary
information section.
2.6. Immunofluorescence Characterization. Immunofluores-
cence staining was performed to examine the expression of
major ECMproteins in native and spin coated ACM. Samples
were fixed in 4% formaldehyde for 20min at RT followed by
blocking in 3% BSA for 1 hr. The fixed native and spin coated
ACM samples were incubated with the appropriate dilution
of Phalloidin actin Alexa Flour-488 (Molecular Probes, Invit-
rogen, USA) in 1% BSA in PBS for 45min in dark at RT. All
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the antibodies used in immunofluorescence studies were pur-
chased from Sigma. Primary antibodies against fibronectin
(1 : 500), laminin (1 : 200), and collagen I (1 : 500) were added
to the samples. After an hour of incubation, samples were
washed and incubated with appropriate anti-mouse iso-
type IgG-Alexa Flour-594 (1 : 500) and anti-rabbit IgG-Alexa
Flour-594 (1 : 500) secondary antibodies (Molecular Probes,
Invitrogen). After an hour of incubation, samples were
washed with 1x PBS and mounted in Vectashield mounting
medium containing 4󸀠,6-diamidino-2-phenylindole (DAPI).
Images were captured using acoustooptical beam splitter
confocal microscope (Leica Microsystems, Germany).
2.7. Ex Vivo HSPC Expansion
2.7.1. HSPC Expansion on HS-5 Derived ACM. 24-well TCP-
coated with native or spin coated HS-5 ACM were used
for expansion experiments. Serum-deprived intact HS-5 cells
were used as a cellular control and normal TCP wells without
any matrix or cells were used as negative controls. Mag-
netically sorted HSPC with >90% CD34+ cell enrichment
was suspended in Stemline II serum free media (Sigma)
containing 50 𝜇g/mL penicillin and streptomycin at a density
of 1 × 104 viable cells/mL. The medium was supplemented
with growth factors as indicated—thrombopoietin (TPO,
25 ng/mL), stem cell factor (SCF, 25 ng/mL), interleukin-6
(IL-6, 50 ng/mL), and Flt3 ligand (Flt3, 40 ng/mL) (Millipore,
USA). 1mL cell suspension was placed in each well of the 24-
well plate in triplicate for each substrate, that is, native ACM,
spin coatedACM,TCP, andHS-5 cellular control. All cultures
were placed in an incubator with an atmosphere of 5%O
2
, 5%
CO
2
, and 95% humidity at 37∘C for 8 days, undisturbed and
without amedia change. After 8 days, the cells were harvested
and were processed for immunophenotypic analysis by flow
cytometry and functional CFU-c assays.
2.7.2. Flow Cytometry. Flow cytometry for multilineage
cell surface markers was performed on HSPC before and
after expansion in order to calculate the fold change in
the numbers of lineage-specific progenitors. CD34+CD45lo
phenotype was used for all progenitors committed for
hematopoiesis: CD34+CD133+ and CD34+CD38− for cells
with an early commitment to granulocyte, erythrocyte,
monocyte, and megakaryocyte lineages. 7-Amino-actinomy-
cin D (7-AAD) was added to measure the cell viability.
The methodology for HSPC pre- and postexpansion flow
cytometry analysis was followed as described elsewhere
[15]. Briefly, 2 × 104 HSPC cells (pre- and postexpanded)
were added to Fluorescence-Assisted Cell Sorting (FACS)
tubes containing 100 𝜇L of PBS/2% FACS solution, and
appropriate antibodies and viability dye were added. Stained
cells were incubated at RT in the dark for 20min, followed
by washing with 1x PBS containing 2% FCS to remove
excess antibody. Finally the cell pellets were resuspended in
300 𝜇L fixative solutions (PBS 2%, FCS 1%, formaldehyde
2 𝜇g/mL, and actinomycin D) and stored at 4∘C in the
dark. Data acquisition and analysis were performed within
three days in FACS Calibur flow cytometer using CellQuest
software. Antibodies used in FACS were purchased from
Becton Dickinson Biosciences, USA. For determining the
mean and standard error values, data from three independent
experiments with triplicate samples in every experiment
was used. For determining the fold increase in total cell
number and lineage-specific cells the calculations were done
as follows:
(a) Fold expansion of total cells = Count of total viable cells post-expansion
Count of total viable cells pre-expansion
. (1)
(b) For fold expansion of lineage-specific cells
=
(Lineage-specific cell percentage × Count of total viable cells) post expansion
(Lineage-specific cell percentage × Count of total viable cells) pre-expansion
.
(2)
2.7.3. Colony Forming Unit Assays. Colony forming unit
(CFU) assays to evaluate the functional properties of cells
grown on the two substrates and control surfaces were done
using MethoCult media (H4434) following the standard
protocol described elsewhere [15]. Total 3 × 103 viable cells
were suspended in the media, plated per well as per the man-
ufacturer’s instructions, and incubated for 14 days in 5% CO
2
and 20% O
2
at 37∘C. CFUs were manually counted under the
light microscope following 14 days of incubation. Statistical
significance of the variation in CFUnumbers was based upon
data from three independent experiments. Fold expansion of
CFUs in each culture was calculated as explained for marker-
based cell expansion. CFUs of granulocyte-macrophage
(GM), burst forming units-erythroid (BFU-E), and granulo-
cyte, erythrocyte, monocyte, and macrophage cells (GEMM)
were performed with preculture and postculture HSPC cells.
Using the following formula, fold change in total and each
lineage-specific CFUs was calculated:
Fold expansion of CFU
=
Post-expansion CFU numbers
Pre-expansion CFU numbers
.
(3)
2.8. Statistical Analysis. Experiments were repeated with
three different UCB samples. Experimental data were
expressed as mean ± standard error (SE). One-way ANOVA
was applied to determine the statistical relevance of the total
cell and colony expansion on various substrates using Prism
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(a) (b)
Figure 2: Phase contrast microscope images of HS-5 stromal cells (a) before decellularization and (b) after decellularization (scale bar:
100𝜇m).
(a) (b)
Figure 3:Morphological characterization of native ACM and spin coated ACM. SEM images depicting (a) presence of thick, bulky structures
on native ACM and (b) uniform layer of matrix with the presence of subnanosized globular structures on spin coated ACM (scale bar: 10 𝜇m).
5.0 (GraphPad S) and a value of 𝑝 ≤ 0.05 was considered as
significant.
3. Results
3.1. ACM Characterization
3.1.1. Phase Contrast Microscopy. After HS-5 cells had been
decellularized by treatment with NH
4
OH, the cell debris
was removed leaving behind the ACM. Phase contrast
micrographs of HS-5 cells before (Figure 2(a)) and after
(Figure 2(b)) NH
4
OH treatment clearly demonstrate the
absence of cell nuclei in the decellularized native ACM
(Figure 2(b)). The spindle-shaped cells absorb NH
4
OH-
containing water. They become round and burst due to
excessive accumulation of water leaving behind some cellular
components within the ECM. Complete decellularization
can be confirmed by the absence of intact nuclei. Hence,
decellularization efficiency was further evaluated by staining
with DAPI for the absence of intact DNA.The DAPI staining
of intact HS-5 cells and decellularized ACM is shown in
Supplementary Figure S1.
3.1.2. Scanning Electron Microscopy. SEM analysis of the
native and spin coated ACM showed the microdetailing and
architecture of thematrix surfaces. Native ACM (Figure 3(a))
exhibit the presence of thick bulky structures, which are
the deposited matrix component after decellularization. The
porous surface structure is visible as irregular shape measur-
ing few 𝜇m in diameter. On the other hand, spin coated ACM
(Figure 3(b)) exhibited more uniform layer with the presence
of nanosized globular structures on the entire surface.
3.1.3. Atomic Force Microscopy. AFM analysis of native and
spin coated ACM was performed to understand the topo-
graphical differences (thickness, roughness, and uniformity)
on the surface of the matrices. To analyze the 2D and 3D
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Figure 4: Height variation measurement by 2D and 3D AFM of ACM. (a) 2D AFM of native ACM, (b) 2D AFM of spin coated ACM, (c)
3D AFM of native ACM, (d) 3D AFM of spin coated ACM, (e) line scan to measure the height variations in native ACM, and (f) line scan to
measure the height variations in spin coated ACM. Arrows indicate variations in the height of native and spin coated ACM.
asymmetry of the coated surfaces, line scan AFM imaging
was done for both the substrates. Based on 2D analysis, large
variations in surface height and other structural irregularities
could be seen on the native ACM (Figure 4(a)) as compared
with the spin coated ACM, which was more uniform and
symmetrical (Figure 4(b)).The 3D data analysis (Figures 4(c)
and 4(d)) showed these differences more clearly as dark
and light shades. The units and dimensions of representative
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Figure 5: ACM thickness and surface roughness measurement in AFM. (a) Representative figure of Z-scan tomeasure the thickness of native
ACM, (b) Z-scan to measure the thickness of spin coated ACM, (c) representative graph of surface roughness profile in native ACM, and (d)
representative graph of surface roughness profile in spin coated ACM.
line scans of native and spin coated ACM are shown in
Figures 4(e) and 4(f). The highest and lowest peaks on native
ACMwere at +60 nm and −40 nm, respectively (Figure 4(e)),
and that for spin coated ACM were at +12 nm and −4 nm,
respectively (Figure 4(f)). The high range of difference in the
values of surface height suggests that native ACM surface was
more irregular than spin coated ACM.The spin coated ACM
showed repetition of similar surface height profile in a line
scan.
The thickness of matrix deposited on the native and
spin coated ACM was measured by AFM. The average
thickness was calculated to be equal to the difference between
the scratched and the exposed glass surface and the average
matrix deposit level. In native ACM, different levels of
thickness were observed to be consistent with the mixed
symmetries present on the surface.The average thickness was
calculated by scanning random segments in different frames
and multiple scans were used for the final calculation in both
the substrates.The representativeAFM image of the thickness
profile of native ACM is shown in Figure 5(a) and that of spin
coated ACM is shown in Figure 5(b). The thickness of the
native ACM was calculated to be 583 ± 130 nm and that of
spin coated ACM was 160 ± 11 nm (Supplementary Table 2).
The thickness profile generated by AFM indicated that spin
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Figure 6: Cytochemical characterization of ACM (“(a), (c), (e), and (g)” indicate native ACM and “(b), (d), (f), and (h)” indicate spin coated
ACM). (a) and (b) Masson’s trichrome staining of collagen, (c) and (d) Picro Sirius Red staining of fibrillar collagen, (e) and (f) Alcian Blue
staining of proteoglycans, (g) and (h) Safranin-O staining of GAGs (scale bar: 100 𝜇m).
coated ACM are indeed thin film matrices layered uniformly
over an area whereas the native ACM are thicker matrices.
For measurement of surface roughness, a total of four
scans from random segments of each substratewere used, and
the average root mean square roughness of native and spin
coated ACM was calculated by the WSxM v4.3 software. The
results are shown in Figures 5(c) and 5(d), respectively and,
as can be seen, the values were 26±16 Ra for native ACM and
51.25 ± 3.4 Ra for spin coated ACM (Figure 5(d)). SEM and
AFM analysis of blank coverslips is shown in Figure S2.
3.2. Cytochemical Characterization. Cytochemical staining of
substrates showed that both native and spin coated ACM
depict similar retention of matrix constituents such as col-
lagen (Figures 6(a) and 6(b)), fibrillar collagen (Figures 6(c)
and 6(d)), proteoglycans (Figures 6(e) and 6(f)), and GAGs
(Figures 6(g) and 6(h)). In contrast to the native ACM, where
the stains are retained by deposited matrix leaving spaces in
between, the spin coated ACM exhibit more uniform stain
retention. The differences in the physicochemical properties
of the substrates did not seem to have affected the qualitative
distribution of matrix proteins on the two substrates. Cyto-
chemical staining images forMasson’s trichrome, Picro Sirius
Red, Alcian Blue, and Safranin-o on blank TCP are shown in
Figure S3.
3.3. Immunofluorescence Characterization. Antibody stain-
ing of native and spin coated ACM confirmed the presence
of all the three major ECM molecules, that is, fibronectin
(Figures 7(a) and 7(b)), collagen type I (Figures 7(c) and
7(d)), and laminin (Figures 7(e) and 7(f)) in both the
substrates. No nuclear staining (as shown by DAPI staining)
or presence of cytoplasmic actin (as shown by Alexa Fluor-
488 phalloidin actin staining) could be seen. Native ACM
exhibited structural features that were similar to the native
stromal structure, whereas the spin coated ACM exhib-
ited uniformly distributed nonfibrous particulate matrix
on the surface (Figures 7(e) and 7(f)). Control images of
immunofluorescence studies are shown in Figure S4.
3.4. HSPC Expansion on ACM
3.4.1. HSPC Cell Morphology. After 8 days of HSPC expan-
sion, images were taken on a light microscope (Axiovert Live
cell 200M, Carl Zeiss, Germany). The maximum increase in
cell number after 8 days of expansion in culture was observed
on spin coated ACM followed by native ACM (Figure 8).
HSPC cell morphology was best retained in native and spin
coated ACM as compared to the control substrates.
3.4.2. Immunophenotypic Analysis of HSPC Expansion. The
flow cytometry data was obtained from three different
UCB derived HSPC and the average cell viability and per-
centage of each lineage-bearing cell were calculated. The
corresponding dot plots for CD34+CD45lo, CD34+CD38−,
and CD34+CD133+ cells, before and after expansion on the
substrates, have been shown in Figure 9. Fold expansion
was calculated according to the formula discussed earlier in
Section 2.
Our results indicate that spin coated ACM could better
support the expansion of CD34+CD133+ bearing progenitors
44-fold on spin coated ACM versus 35-fold on native ACM
in comparison to the controls (Figure 10(a)). Spin coated
substrates were also good for expanding committed HSPC
Stem Cells International 9
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Figure 7: Characterization of native and spin coated ACM by immunostaining (“(a), (c), and (e)” indicate native ACM and “(b), (d),
and (f)” indicate spin coated ACM). (a) and (b) Immunostaining of fibronectin, (c) and (d) immunostaining of collagen, and (e) and (f)
immunostaining of laminin (scale bar: 10𝜇m).
(CD34+CD45lo), as compared to TCP and cellular con-
trol but not for undifferentiated CD34+CD38− progenitors
(Figure 10(a)).
3.4.3. Colony Forming Cells Analysis of HSPC Expansion.
CFU-c data were obtained from three independent experi-
ments of HSPC expansion on ACM substrates and controls.
Comparison of results of expansion between different sub-
strates is represented in Figure 10(b). Although expansion
of all cell types (CFU-GM, BFU-E, CFU-GEMM, and total
viable cells) was observed on both ACM, the expansion
of BFU-E (170-fold) was efficient in spin coated ACM as
compared to the TCP and cellular controls. CFU-GM (120-
fold) and CFU-GEMM (70-fold) were more efficient and
significant on spin coated ACM as compared to the native
ACM, TCP, and cellular controls (Figure 10(b)).
4. Discussion
The discovery of HSPC and its application for restoration
of normal hematopoiesis in malignant and nonmalignant,
haematological disorders [2] has been a landmark in the
field of cell transplantation. Very often, the success of this
treatment is limited due to the low numbers of repopulating
stem cells in the graft.This deficiency can be improved by the
expansion of HSPC ex vivo so that the requirement of a large
number of uncommitted primitive cells to repopulate the BM
and restoration of normal hematopoiesis is met.
The fact that the hematopoietic niche regulates HSC self-
renewal and proliferation in vivo has inspired researchers to
recreate niche like in vitro conditions for achieving lineage-
specific HSPC growth. The hematopoietic niche in BM is a
complex biological milieu; it comprises several cellular and
molecular components, soluble growth factors, and nonsol-
uble ECM [6]. Both the cellular and extracellular counter-
parts of the hematopoietic niches have been investigated
extensively to understand their stem cell regulatory activities
and properties [16]. It has been demonstrated that niche
components can regulate adhesion, proliferation, differenti-
ation, and survival of HSPC in the BM [6]. ECM molecules
anchor growth factors and they provide mechanical strength
to the niche for facilitating interactions between other niche
components [17].
Earlier studies have focussed on individual ECM com-
ponents for HSPC expansion, which do not represent the
in vivo complexity of the hematopoietic niche [18–20]. For
example, a cocktail of different ECM molecules did not give
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TCP Cellular control
Native ACM Spin coated ACM
Figure 8: UCB HSPC expansion on various ACM and control surfaces. (a) TCP—no matrix. (b) Cellular control (stromal cells). (c) Native
HS-5 ACM. (d) HS-5 spin coated ACM.
significant ex vivo expansion of HSPC probably because they
did not provide all the required extracellular signals necessary
for HSPC expansion in vivo [11]. Our study has succeeded
on this account because we have used the entire ACM,
which potentially contain all ECM molecules along with
associated growth factors and other regulatorymolecules that
are required for HSPC expansion. In this report, we have
demonstrated that ACM derived from human BM stromal
cell line, both in native or spin coated forms, could efficiently
support ex vivo HSPC expansion. We have also shown that
these ACM are enriched in fibronectin, laminin, collagen,
and ECM-associated growth factors as observed in the ECM
of in vivo hematopoietic niches [21, 22]. Previous studies
have demonstrated thatHSPC can enhance their functions by
directly binding to ECM molecules; for example, fibronectin
enhancesCFU-GMandBFU-E progenitor cell growth ex vivo
by binding to 𝛼4 and 𝛼5 integrins on these cells [23]; similarly
immobilized fibronectin used as 3D scaffolds [24] or coatings
and fibrillar collagen-I associated with glycophosphoprotein
and osteopontin support the expansion of UCB derived
HSPC [13]. We have demonstrated the enhanced expansion
of HSPC onHS-5 derived ACM. Our results suggest that HS-
5 derived ACM mimic the in vivo properties of the vascular
niche in the BM. To our knowledge, this is the first report
on the use of ACM derived from human stromal cells that
significantly supports the expansion of UCB derived HSPC.
An additional advantage of our results is that HS-5 derived
ACM can be used in the clinical studies where xenogeneic
substrates are not permitted due to immunological consid-
erations. We also demonstrate that, along with biochemical
properties, the topographical and physical features also play a
critical role in HSPC growth and survival. We could observe
an improvement in the lineage-specific HSPC expansion of
committed progenitor cells population on spin coated HS-5
ACM as compared to native ACM. One possible explanation
is that the topographical differences in surface roughness,
thickness, and the uniform nanoglobular surface architecture
of the substrates could be responsible for this functional
improvement. With the spin coating, the matrix proteins
are more uniformly distributed which probably helps in
improving the total surface area of interaction of the cells with
the matrix components. The thickness of the matrix is also
known to affect the fate of the cells [25]. It has been shown that
thinner matrices having higher elastic modulus and stiffness
can better mimic the rigid bone microenvironment [25]. The
nanoglobular surface features of tissue-engineered substrates
are also known to support better osteogenic functions. Sur-
facemicrotopography and roughness have also been reported
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Figure 10: (a) Immunophenotypic analysis for measurement of fold increase in UCB HSPC of different lineages after expansion on native
ACM, spin coated ACM, TCP, and cellular control. The graphs represented in the figure are the means of three independent experiments.
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(∗𝑝 ≤ 0.05, ∗∗𝑝 ≤ 0.005, #no significance, and 𝑛 = 3).
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to play an important role in the differentiation of MSCs [26]
and embryonic stem cells [27] and in the adhesion, spreading,
proliferation, and differentiation of osteogenic cells [28].
Based on our results, we propose that topographical
features of spin coated ACM that are thinner (3.5-fold) and
more rough (2-fold) than native ACM can support a better
expansion of committed progenitor of hematopoietic cell
populations.These topographical features such as uniformity,
stiffness, and roughness of the spin coated ACM could have
contributed to the improved expansion in spin coated ACM.
Our data confirm that an optimum substrate topography and
roughness are necessary for achieving enhanced availability
of the nutritive medium and growth factors to the cells, and,
therefore, such surfaces are better than others for supporting
all cell functions.
Recent reviews also highlight the use of various technolo-
gies in the development of efficient biomaterials, using one
or more ECM components for tissue engineering applica-
tions [29–31]. Such advancements in biomaterial designing
can be applied to extract maximum potential of human
tissue-specific ACM without compromising the functional
properties of individual ECM components to get enhanced
expansion of lineage-specific HSPC cells ex vivo.
5. Conclusion
Our report describes a simple and novel method to prepare
native and spin coatedACM thatmimic functional properties
of the hematopoietic niche in human BM. ACM prepared
by our method can provide better understanding of physic-
ochemical and topographical properties of hematopoietic
niches and reveal novel regulatory roles of soluble and ECM
bound signallingmolecules. Since thematrix can be prepared
in advance and stored, this can be used as a simple coating
material with a known concentration, thereby minimizing
the variation that is seen when using the feeders cells as
culture system. The native and spin coated ACM can be
stored in sterile conditions for a longer period as compared
to conventional biological substrates. Our methodology also
provides a general protocol to prepare ACM from other cell
sources (e.g., embryonic fibroblasts and foreskin fibroblasts)
and replace their use as feeder layers to minimise variations
in various tissue engineering experimental setups.
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